Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure (Q43651415)

25 November 2017

Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure (English)

1 reference

25 November 2017

congestive heart failure

1 reference

Nasser A

1

1 reference

25 November 2017

Dietz JR

2

1 reference

25 November 2017

Siddique M

3

1 reference

25 November 2017

Patel H

4

1 reference

25 November 2017

Khan N

5

1 reference

25 November 2017

Antwi EK

6

1 reference

25 November 2017

San Miguel GI

7

1 reference

25 November 2017

McCormick MT

8

1 reference

25 November 2017

Schocken DD

9

1 reference

25 November 2017

Vesely DL

10

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

American Journal of Cardiology

25 November 2017

1 reference

25 November 2017

88

1 reference

25 November 2017

1

1 reference

25 November 2017

23-29

1 reference

Release of kaliuretic peptide during immersion-induced central hypervolemia in healthy humans

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Atrial natriuretic peptide(31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Two new hormones: prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Change in plasma immunoreactive N-terminus, C-terminus, and 4,000-dalton midportion of atrial natriuretic factor prohormone with hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Increased Release of the N-Terminal and C-Terminal Portions of the Atrial Natriuretic Factor Prohormone during Immersion-Induced Central Hypervolemia in Cirrhotic Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Pharmacokinetic characterization of the postdistribution phase of prohormone atrial natriuretic peptides amino acids 1-98, 31-67, and atrial natriuretic factor during and after rapid right ventricular pacing in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Atrial natriuretic peptide fragments in dogs with experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Lack of inhibition of vasopressin-stimulated NA+K+ATPase by atrial natriuretic factor in the rat renal medullary thick ascending limb of Henle's loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901579-X

10.1016/S0002-9149(01)01579-X

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference